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Abstract
Rationale
Respiratory infections are common after strenuous exercise, when salivary immunity may
be altered. We aim to investigate changes in salivary immunity after a marathon and its rela-
tionship with lower respiratory tract infections (LRTI) in healthy non-elite marathon runners.
Methods
Forty seven healthy marathon runners (28 males and 19 females) who completed the
42.195 km of the 2016 Barcelona marathon were studied. Saliva and blood samples were
collected the day before the marathon and two days after the end of the race. Salivary IgA,
antimicrobial proteins (lactoferrin, lysozyme) and chemokines (Groα, Groβ, MCP-1) were
determined using ELISA kits in saliva supernatant. Blood biochemistry and haemogram
were analyzed in all participants. The presence of LRTI was considered in those runners
who reported infectious lower respiratory tract symptoms during a minimum of 3 consecutive
days in the 2 weeks after the race.
Results
Eight participants (17%) presented a LRTI during the 2 weeks of follow-up. Higher lysozyme
levels were detected after the race in runners with LRTI when compared with those without
infection. A decrease in salivary lysozyme, Groα and Groβ levels after the race were
observed in those runners who did not develop a LRTI when compared to basal levels. Sali-
vary Groα levels correlated with basophil blood counts, and salivary lysozyme levels corre-
lated with leukocyte blood counts.
Conclusions
LRTI are common after a marathon race in non-elite healthy runners. Changes in salivary
antimicrobial proteins and chemokines are related to the presence of LRTI and correlate
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with systemic defense cells, which suggest an important role of salivary immunity in the
development of LRTI in non-elite marathon runners.
Introduction
The number of non-elite runners participating in marathons had increased dramatically in the
last ten years [1]. Several studies have demonstrated that marathons and ultramarathons may
alter immune function and increase the risk of respiratory tract infections [2–4]. Within two
weeks of completing such strenuous exercise, the risk of infection increased 100% to 500% [5]
and around 25% of finishers reported respiratory symptoms [3].
Salivary Immunoglobulin A (sIgA) is the most common antibody on the mucosal surface.
Different studies have analyzed changes in sIgA following strenuous exercises and their poten-
tial relationship with respiratory symptoms, with conflicting results [6–8]. Other studies have
suggested that immune factors present in mucosal secretion, including antimicrobial peptides
(AMPs) and immune mediators such as chemokines, changed after prolonged running. An
increase in salivary lactoferrin, one of the most abundant AMPs, has been described in partici-
pants in a 50 km ultramarathon [9]. Furthermore, chemokines such as Growth-Regulated
Oncogene-alpha (Groα or CXCL1), growth-Regulated Oncogene-beta (Groβ) and monocyte
chemoattractant protein 1 (MCP-1) have demonstrated an important role in the regulation of
local immunity against infections by contributing to the tissue infiltration of leukocytes [10].
Experimental studies showed that serum levels of these inflammatory mediators increased
markedly in response to exercise in mice [11]. However, limited data regarding salivary IgA,
AMPs, chemokines and the presence of lower respiratory tract infections (LRTI) in marathon
runners are available.
We hypothesized that non-elite marathon runner who experienced changes in their salivary
immunity would be more prone to developing a respiratory infection. Therefore, our aim was
to determine salivary levels of IgA, AMP and inflammatory markers before and after a mara-
thon and their relationship with the development of LRTI.
Materials and methods
Subjects
Forty seven healthy non-elite marathon runners (28 males and 19 females) completed the
42.195 km of the 2016 Barcelona Marathon. Mean finishing time was 3 hours and 38 min (±41
min). Study participants were recruited using an announcement in the marathon newsletter
that all marathon runners received two weeks prior to the race. Participation was voluntary in
all cases. The study was approved by the local ethics committee “Comite´ E´tic de Investigacio´
Clı´nica de la Fundacio´ de Gestio´ Sanitaria del Hospital de la Santa Creu i Sant Pau de Barce-
lona”, project number IIBSP-SUMMIT-2016-02. All participants gave signed informed
consent.
All runners were asked to report any incidence of respiratory symptoms 2 weeks before and
after the race. Runners who reported respiratory symptoms 2 weeks before marathon were
excluded from the study. LRTI was defined according the clinical definition proposed by the
European Respiratory Society and European Society for Clinical Microbiology and Infections
disease [12]: acute illness (present for 21 days or less) characterized by cough as the main
symptom, with at least one other respiratory tract symptom (sputum production, dyspnea,
wheeze or chest discomfort/pain) and no alternative explanation. In addition, all runners had
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to report at least one determination of fever (�38˚C) and duration of symptoms must be
higher than 3 days in order to exclude those symptoms induced only by strenuous exercise. All
runners with suspected LRTI were follow-up until a breakdown of symptoms was reported.
Saliva and blood collection
Saliva and blood samples were collected one day before the marathon and two days after the
end of the race. Saliva was collected into clean, sterile tub, maintained at 4˚C before centrifuga-
tion at 9500xg for 10 minutes at 4˚C. Supernatant was aspirated and 3 different aliquots were
frozen at -20˚C until use. Three 10 mL blood samples were obtained from the antecubital vein
and were transferred immediately (in less than 2 hours) to the laboratory for analysis.
Saliva analysis
The saliva samples were then thawed and total protein saliva was quantified using the Qubit
protein Assay Kit (Thermofisher Scientific). Salivary IgA (Human IgA Platinum ELISA,
ebioscience, Affymetrix, Santa Clare, CA), lactoferrin, lysozyme (AssayPro, St. Charles, MO,
USA), Groα, Groβ and MCP-1 (Elabscience, Houston, Texas) were measured by ELISA
according to the manufacturer’s instructions. The limit of detection for IgA was: 1.6 ng/ml;
lactoferrin: 0.625 ng/ml; lysozyme: 0.0781 ng/ml; Groα: 15.63 pg/ml, Groβ: 15.63 pg/ml and
MCP-1: 15.63 pg/ml. Data were expressed as the concentration of each molecule relative to
total saliva protein concentration [13]. Those determinations of relative salivary IgA concen-
tration with a ratio higher than 1 were excluded of the study due to possible contaminations
[14]. All determinations were performed in triplicate.
Blood analysis
Blood samples were centrifuged at 800xg at 4˚C for 10 min in a bench centrifuge. Super-
natant (plasma) was aliquoted and stored on dry ice until all samples were frozen at
-80˚C. Sodium and potassium plasma concentrations were determined using ion selective
electrodes with an ionized sodium/potassium analyzer KNA1 (Radiometer, Copenhagen,
Denmark). Creatinine and urea were measured using an AU5800 analyzer (Beckman
Coulter, Hospitalet de Llobregat, Spain). C-reactive protein was determined using the
AU-5800 Chemistry Analyzer (Bekman Coulter, Miami, FL, USA). Complete blood
counts were performed with the Unicel DxH800 automated hematology analyzer (Beck-
man Coulter, Miami, FL, USA).
Statistical analysis
Statistical analyses were performed using Graph Pad Prism 5 software. The Kolmogorov-
Smirnov test was applied to test the normal distribution of the data. All variables with a
normal distribution were reported as mean ± standard deviation (sd). T-test and paired t-
test respectively were used for the comparison of independent and related variables with
Gaussian distribution. The Wilcoxon test and Mann Whitney test were used for the com-
parison of related variables and for the comparison of independent variables respectively
with non-normally distributed data. Pearson’s and Spearman’s coefficients respectively
were used to correlate changes between normal and non-normal distributed variables.
Chi-square tests were used for the comparison of frequencies. P values less than 0.05 were
considered significant.
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Results
Study participants
Table 1 shows demographic and laboratory test results prior to the marathon for all partici-
pants. Median age was 30 years old, median years of training were around 10 and training
hours per week were around 6. All laboratory tests performed were in the normal range.
No differences between males and females were found in baseline characteristics (data not
shown), except for Body Mass Index (BMI), which was higher in males than in females (23.6
±2.1 vs 20.7 ± 1.4, p = 0.01).
Lower respiratory tract infections
Eight participants (17%) reported a LRTI during follow-up. No differences in demographics
and laboratory findings between infected and non-infected participants were found prior to
the marathon (Table 1). All runners with LRTI experienced a breakdown of the symptoms
before 14 days of their onset and were fully recovered within one month after the race.
Salivary IgA
No differences before and after the marathon were found in total salivary protein concentra-
tion (2.34±1.16 mg/ml vs 2.37±0.97 mg/ml, respectively) nor in salivary IgA levels normalized
to total salivary protein (0.39±0.25 vs 0.35±0.24) (Fig 1A). In addition, no differences in IgA
levels before and after the race were found between infected and non-infected runners (Fig
1B), and no differences were observed between male and females before marathon in salivary
IgA/protein.
Table 1. Demographic and biochemical charcateristics from marathon runners.
All runners Non LRTI LRTI p value
Sex (M/F) 28/19 21/18 7/1 NS
Age 39.0±7.1 39.1±7.4 38.6±5.6 NS
BMI 22.6±2.4 22.3±2.3 23.8±2.8 NS
Years training 9.7±9.3 10.2±10.0 7.4±4.0 NS
Hours training/week 6.5±3.7 6.5±3.9 6.6±2.6 NS
Glucose (mg/dl) 84.7±14.4 85.5±15.4 81.0±7.9 NS
Na (mEq/l) 139.3±1.6 139.2±1.4 139.8±2.5 NS
K (mEq/l) 4.0±1.6 4.0±0.2 4.0±0.3 NS
Leukocytes % 6.9±1.6 6.8±1.4 7.6±2.2 NS
% Lymphocytes 34.7±7.5 34.8±6.5 34.1±11.9 NS
% Monocytes 8.3±2.7 8.5±2.9 7.7±1.3 NS
% Neutrophils 53.9±8.5 53.5±7.5 55.8±12.6 NS
% Eosinophils 2.3±1.7 2.4±1.7 1.7±1.5 NS
% Basophils 0.6±0.4 0.7±0.4 0.4±0.1 NS
Hb (g/dl) 14.1±1.1 14.5±0.9 14.0±1.2 NS
Hematocrit (%) 41.8±3.3 41.6±3.4 42.8±2.9 NS
Platelets (x109/l) 215.8±50.3 214±48 220±62 NS
CRP (mg/dl) 1.3±2.2 1.4±2.4 1.0±0.5 NS
BMI, Body Mass Index; Hb, hemoglobin; CRP, C-reactive protein.
LRTI: Lower Respiratory Tract Infection
NS, non significant
https://doi.org/10.1371/journal.pone.0206059.t001
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Salivary antimicrobial proteins
No differences before and after the race were observed in salivary lactoferrin (0.013±0.01 vs
0.010±0.007) and salivary lysozyme levels (0.0094±0.007 vs 0.0078±0.007). Furthermore, no
differences between the sexes were observed before the marathon.
When runners with and without LRTI were compared, we observed no differences in sali-
vary lactoferrin levels before and after the race. However, those runners who developed a LRTI
showed higher levels of salivary lysozyme after the race compared to those who did not develop
it (0.012±0.01 vs 0.006±0.004, p = 0.02). In addition, a decrease in lysozyme levels was
observed in runners who did not develop LRTI when levels before and after the race were com-
pared (0.010±0.007 vs 0.006±0.004, p = 0.003) (Fig 2).
Salivary chemokines
No differences before and after the race were observed regarding salivary Groα Groβ and
MCP-1. However, runners who did not develop LRTI showed a significant decrease in salivary
Groα and Groβ levels after the race (Groα, 0.37±0.15 vs 0.30±0.14, p = 0.02; Groβ 0.47±0.17 vs
0.37±0.18, p = 0.03) (Fig 3A and 3B). No differences in MCP-1 levels were found.
Systemic correlations
Before the race, salivary lactoferrin levels had a weak but statistical significant negative rela-
tionship with blood lymphocyte counts (r = -0.13, p = 0.04) and salivary Groα had a weak posi-
tive correlation with the percentage of blood basophils (r = 0.22, p = 0.03) (Fig 4A and 4B).
After the race, salivary lysozyme correlated positively with the absolute number of blood
leukocytes (r = 0.26, p = 0.006) (Fig 4C).
Discussion
In our study we observed that LRTI is common in non-elite runners following a marathon and
we demonstrated that runners who developed a LRTI had different immunological profile in
their saliva. Specifically, a decrease in salivary lysozyme, Groα and Groβ levels was observed in
those runners who did not develop a LRTI when levels before and after the race were com-
pared. In addition, higher levels of lysozyme were detected after the race in runners with LRTI
Fig 1. Salivary sIgA from marathon non-elite runners. Salivary sIgA was determined by ELISA as described in
Materials and Methods. (A) sIgA content before and after marathon. (B) sIgA content before and after marathon based
on the development of LRTI after marathon. Results were showed as the concentration of sIgA relative to total protein
content. P values were determined by paired non parametric Wilcoxon t-test.
https://doi.org/10.1371/journal.pone.0206059.g001
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compared with those without infection. These findings suggest that immunological status may
be important for the development of a LRTI after a marathon.
Fig 2. Salivary lysozyme from marathon non-elite runners before and after the marathon. Results were showed as
the concentration of lysozyme relative to total protein content. P values were determined by unpaired t-test and paired
Wilcoxon test.
https://doi.org/10.1371/journal.pone.0206059.g002
Fig 3. Salivary Groα and Groβ. Salivary (A) Groα and (B) Groβ were determined by ELISA as described in Materials and Methods before and after marathon. P values
were determined by unpaired Mann Whitney t-test and paired Wilcoxon test.
https://doi.org/10.1371/journal.pone.0206059.g003
Salivary immunity in runners
PLOS ONE | https://doi.org/10.1371/journal.pone.0206059 November 21, 2018 6 / 11
Several data have been reported reflecting the importance of the immune system in the
development of LRTI after strenuous exercise. We observed that 17% of marathon runners
develop LRTI symptoms within 2 weeks after marathon, which is concordant to other studies
[7,15]. Although the effect of close proximity between runners during the race cannot be ruled
out, extreme effort has been shown to alter immune defenses by increasing inflammation in
the respiratory tract [16]. Different studies have postulated that a combination of several
immune, biochemical and hematological parameters participate in the severe stress on the
body resulting from such exercise and that they may be associated with an increased suscepti-
bility to developing infections [17]. Salivary IgA (sIgA) is one of the most widely-studied
parameters [7]. Some studies have pointed to the usefulness of sIgA as a noninvasive bio-
marker of mucosal immunity and LRTI risk [18,19]. However, other studies have suggested
that reductions in sIgA cannot be solely responsible for the decline in immune function that
may lead to LRTI [20]. In our cohort of runners, we did not observe differences in sIgA as
other authors previously showed [21]. We observed that sIgA represented about 40–60% of
total salivary protein, which is concordant with previous studies [22,23] but higher than other
ones [24]. Most of the studies were carried out few hours after exercise [25,26] and we wanted
to evaluate two days after finishing the marathon, since few data regarding the recovery period
and its influence on the development of LRTI are available [7].
Salivary antimicrobial proteins (sAMPs) such as lysozyme and lactoferrin protect the respi-
ratory tract from invading microorganisms and have been linked with an increased infection
risk in athletes [27]. In our cohort of runners, we observed no differences in the levels of saliva
lysozyme before the race. However, runners who did not develop LRTI showed a decrease in
lysozyme after the marathon. In contrast, those runners who developed a LRTI showed higher
Fig 4. Correlation of salivary lactoferrin, Groα and lysozyme with systemic haematological parameters. (A)
Negative correlation between salivary lactoferrin with blood lymphocytes, (B) positive correlation between salivary
Groα and blood basophils and (C) positive correlation between salivary lysozyme and blood leukocytes, were found.
Pearson’s and Spearman’s coefficients were respectively used to correlate changes between normal and between non-
normal distributed variables.
https://doi.org/10.1371/journal.pone.0206059.g004
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levels of salivary lysozyme after the race compared to those runners who did not develop
LRTI. Our findings are in line with other studies showing a decrease in salivary lysozyme
immediately after an ultra-marathon, though this decrease was not related to the presence of
LRTI [5]. However, other studies did not observe differences in salivary lysozyme levels after a
50 km race [25]. These discrepancies could be the consequence of different levels of effort dur-
ing exercise. Interestingly we observed an inverse relation between salivary lactoferrin and
blood lymphocyte counts before the race, which may be explained by the mobilization of neu-
trophils to maintain blood homeostasis. Previously, Inoue H et al. [28] described an immediate
increase in serum lactoferrin concentrations immediately after running exercise and serum
lactoferrin may play an antibacterial role in host defenses before the mobilization of neutro-
phils into the circulating pool. We also observed a positive correlation between blood leuko-
cyte counts and the content of saliva lysozyme after the marathon. It has been observed that
exercise sessions in both humans and animal models resulted in the stimulation of neutrophil
degranulation releasing lysozyme from blood neutrophils [29]. All of these findings suggested
that systemic alterations may affect the content of saliva lactoferrin and lysozyme in runners
and may contribute to the development of LRTI after races. Nevertheless, we cannot exclude a
process of dehydration during the marathon, since it has been demonstrated that dehydration
decreases saliva antimicrobial proteins [30,31]. Dehydration can therefore affect the content of
saliva AMPs, and further studies are needed to better elucidate its importance, though we did
not observe differences in protein content before and after the race.
Different chemokines have demonstrated a potential role in the regulation of immune
response during exercise [32]. We also found that Groα and Groβ, which are key components
in the attraction of neutrophils to the site of inflammation, decreased after the race in runners
who did not develop a LRTI. It has been described that daily moderate exercise suppressed
Groα [33] and, in experimental models, exercise down regulated multiple inflammatory cyto-
kines and chemokines including Groα and MCP-1 [34,35] and had a systemic anti-inflamma-
tory effect, reducing Groα, Groβ and MCP-1 [36,37]. These findings were observed in runners
who did not develop LRTI, suggesting that they had a better inflammatory regulation response
that may protect against infection. Therefore, athletic performance is both a stress factor and
an adaptive response to exercise that can be modulated by training, reduce inflammation and
help to prevent disease. Further studies are needed to better understand the relationship
between salivary immunity and systemic inflammation as a key factor in the development of
LRTI after exercise.
Interestingly, we observed a positive correlation between blood basophils and salivary Groα
level before the race. Sastre B et al, identified basophils as a new player in the status of bron-
chial inflammation in athletes [38]. We observed that non LRTI runners had a higher percent-
age of systemic basophils, although differences were not statistically significant.
Our study has several limitations. First, due to the small number of runners included, the
results should be validated in other studies before generalizing them. Second, since some data
reported the effect of feeding in post exercise saliva AMPs proteins [39] we cannot exclude
feeding related affectations in the determinations of AMPs in our cohort of runners. Third,
levels of leukocyte subpopulations after the race were measured 48 hours after the marathon
and other determinations at 7 or 14 days would be helpful to better characterize systemic
response in marathon runners, and it should be an important point to be taken into account in
further studies. And fourth, infectious agents that caused LRTI are not described due to the
absence of microbiological studies. Further studies including bacterial and viral determina-
tions would be very helpful to clarify this important issue.
In conclusion, non-elite runners who developed a LRTI after a marathon showed a differ-
ential profile of saliva IgA, AMPs and chemokines compared to those runners who did not
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develop infection. Therefore, exercise training and post-marathon recovery would be impor-
tant in the immunological profile and the risk of developing a LRTI. Further studies are
needed to better understand the underlying mechanisms and the impact of salivary immunity
and its regulation in the prevention and development of LRTI in non-elite marathon runners.
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